An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had ...

Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Not only can the drug metformin help to effectively manage type 2 diabetes, but it may also give older women a better chance of living to the grand old age of 90, according to research published in ...

A US team has linked metformin use in older women with type 2 diabetes to a 30% lower risk of dying before 90. But does this hint at exceptional longevity or just better disease control? Could a cheap ...

Abbott partners with Novo Nordisk to launch Extensior, a second Ozempic brand for type 2 diabetes management in India.

COPENHAGEN (Reuters) - Novo Nordisk plans to invest up to 20 billion Danish crowns ($3.65 billion) on developing diabetes tablets intended to replace traditional insulin injections, it said on Monday.

A growing body of research suggests the brain plays a central role in diabetic ketoacidosis, opening the possibility of treating type 1 diabetes in an entirely new way.